Clinical Trials Directory

Trials / Completed

CompletedNCT01141192

The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Augusta University · Academic / Other
Sex
All
Age
19 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Type 2 diabetes is more common among African Americans than Caucasians. African Americans are also at a higher risk for lower levels of vitamin D compared to other ethnic groups. The investigators don't yet know if there is a connection between not having enough vitamin D and type 2 diabetes in African Americans. Researchers have found that the less vitamin D Caucasians had the higher the chance they would have type 2 diabetes but it is less clear if this is the case for African Americans. The investigators want to better understand how vitamin D status and diabetes risk are linked in African Americans. Also, the investigators want to see if supplementation with vitamin D will improve your blood pressure, blood sugar, \& insulin. All of these are in some way related to diabetes. The investigators want to measure changes in blood sugar \& blood pressure in people who do not have diabetes with the hope of learning new information to help treat those that do have diabetes. The investigators hypothesize that vitamin D status is related to diabetes risk measured by hemoglobin A1c (a test of glucose level over time), fasting glucose and insulin in non-diabetic African American adults and that body weight status may affect vitamin D status in response to vitamin D supplements compared to placebo.

Detailed description

Participants will be randomly assigned to receive either a 60,000 IU vitamin D3 supplement every four weeks or an inactive placebo. All investigators and the participants will be blinded to the assignment group of each participant until all testing is completed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTvitamin D3, cholecalciferol1 gelcap of 50,000 IU vitamin D3 plus 2 gelcaps of 5,000 IU vitamin D3 each; a total of 60,000 IU vitamin D3 dosed four weeks apart at weeks 0, 4, 8, and 12 of the 16 week study.
DIETARY_SUPPLEMENTInactive comparatorThe inactive comparator dose provided was identical in appearance to the active comparator but contained no vitamin D3

Timeline

Start date
2010-01-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2010-06-10
Last updated
2010-06-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01141192. Inclusion in this directory is not an endorsement.